New App Helps Predict Pediatric Transplant Need Research and innovation hub at the BARE Symposium in Stanford, CA The GLI Pediatric and Rare Liver Diseases team was thrilled to attend...
June 13 is Global Fatty Liver Day June 13 marks Global Fatty Liver Day, and the time to act is NOW! With conditions like obesity and diabetes increasing the risk for fatty liver disease, early...
Deploying Solutions: How Can Veterans Manage Fatty LiverUnderstanding Fatty Liver Disease Fatty liver disease includes a spectrum of liver conditions characterized by excess fat accumulation in the...
Improvement within Clinical Trials Genentech/Roche is enhancing the accessibility of clinical trials by providing comprehensive patient support services. By tackling common barriers to participation...
Global Liver Institute Applauds U.S. Representative Nydia Velázquez’ Reintroduction of The Liver Illness, Visibility, Education and Research Act (LIVER Act)(Washington, D.C., May 31, 2024) –...
Global Leaders Gather to Exchange Best Practices in Liver Health PolicyGlobal Liver Institute Convenes Fruitful Meeting on the Sidelines of WHA77(Geneva, Switzerland, May 29, 2024) – Global Liver...
Exploring Viral Hepatitis: Types, Diagnosis, and TreatmentViral hepatitis, a group of infections affecting the liver, has long been a global health concern. As the seventh leading cause of death...
Congress begins Fiscal Year 2025 appropriations process and the Administration approves new treatments improving the lives of liver disease patients. Join Global Liver Institute to Push Congress to...
New App Helps Predict Pediatric Transplant Need Upcoming Pediatric and Rare Liver Diseases Council Semi-Annual Meeting Our upcoming council meeting is scheduled for May 8, 2024. We're...
Providing Access to Rezdiffra for NASH and the Therapies to Come | AMCP 2024 At the Academy of Managed Care Pharmacy meeting on April 16, experts discussed the emerging landscape of NASH...
Recent News
Global Liver Institute Supports the U.S. House Ways and Means Committee's Markup of Legislation to Expand Obesity Care CoverageGlobal Liver Institute strongly supports the amendment to be considered in the House Ways and Means Committee today to extend coverage for...
Policy, Prevention, and Progress: Fatty Liver & Obesity Dr. Kelly Brownell, Dean Emeritus of the Sanford School of Public Policy at Duke University, has over 35 years of experience studying food systems and obesity. After initially focusing on obesity treatments,...
Perils of AI in Healthcare Donna Cryer, JD and Deborah SobelAs the founder and CEO of Global Liver Institute (GLI), and a liver transplant patient myself, I know it is imperative to connect the dots between real-world experiences of patients and policy solutions....
From Awareness to Action on Global Fatty Liver Day Global Liver Institute Unites the Field in Times of Name Changes and New Treatments(Washington, DC - June 13, 2024) – Today marks the seventh annual Global Fatty Liver Day (formerly International NASH Day), led by...
GLI Celebrates with PBC Patient Community upon U.S. FDA’s Approval of Second-Line Treatment(Washington, D.C. June 10, 2024) – Global Liver Institute (GLI) celebrates the decision of the U.S. Food and Drug Administration (FDA) to provide accelerated approval to...
